Evidence map›Paper›PMID 38952395›Full record

ArticleFrontiers in endocrinology2024

Natural history and surgical outcomes of Rathke's cleft cysts: a Spanish multicenter study.

Edelmiro Luis Menéndez-Torre, Alba Gutiérrez-Hurtado, María Dolores Ollero, Ana Irigaray, Patricia Martín, Paola Parra, Inmaculada González-Molero, Marta Araujo-Castro, Cindy Idrobo, María Dolores Moure and 12 more

Abstract readMulticenter Study
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The endocrine spectrum of Rathke cleft cysts.Frontiers in endocrinology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Edelmiro Luis Menéndez-TorreDepartment of Endocrinology and Nutrition, Hospital Universitario Central de Asturias, Oviedo, Spain.
Alba Gutiérrez-HurtadoDepartment of Endocrinology and Nutrition, Hospital Universitario Central de Asturias, Oviedo, Spain.
María Dolores OlleroDepartment of Endocrinology and Nutrition, Hospital Universitario de Navarra, Pamplona, Spain.
Ana IrigarayDepartment of Endocrinology and Nutrition, Hospital Universitario de Navarra, Pamplona, Spain.
Patricia MartínDepartment of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain.
Paola ParraDepartment of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain.
Inmaculada González-MoleroDepartment of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA Plataforma Bionand, Málaga, Spain.
Marta Araujo-CastroDepartment of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Cindy IdroboDepartment of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, Spain.
María Dolores MoureDepartment of Endocrinology and Nutrition, Hospital Universitario de Cruces, Baracaldo, Spain.
Ana Rosa MolinaDepartment of Endocrinology and Nutrition, Hospital Universitario de Cruces, Baracaldo, Spain.
Betina BiagettiDepartment of Endocrinology and Nutrition, Hospital Universitario Vall d'Hebrón, Barcelona, Spain.
Pedro IglesiasDepartment of Endocrinology and Nutrition, Hospital Universitario Puerta de Hierro, Madrid, Spain.
Miguel PajaDepartment of Endocrinology and Nutrition, Hospital Universitario de Basurto, Bilbao, Spain.
Rocío Villar-TaiboDepartment of Endocrinology and Nutrition, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain.
Alberto PenaDepartment of Endocrinology and Nutrition, Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain.
Almudena VicenteDepartment of Endocrinology and Nutrition, Hospital Universitario de Toledo, Toledo, Spain.
Fernando Guerrero-PérezDepartment of Endocrinology and Nutrition, Hospital Universitari de Bellvitge, Barcelona, Spain.
Fernando CordidoDepartment of Endocrinology and Nutrition, Hospital Universitario de Coruña, Coruña, Spain.
Anna AulinasDepartment of Endocrinology and Nutrition, Hospital Sant Pau, Barcelona, Spain.
Manel MateuDepartment of Endocrinology and Nutrition, Hospital Sant Pau, Barcelona, Spain.
Alfonso SotoDepartment of Endocrinology and Nutrition, Hospital Universitario Virgen del Rocío, Sevilla, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rathke's cleft cysts (RCC) are a common type of lesion found in the sellar or suprasellar area. They are usually monitored clinically, but in some cases, surgery may be required. However, their natural progression is not yet well understood, and the outcomes of surgery are uncertain. The objective of this study is to evaluate the natural history of Rathke's cleft cysts in patients who are clinically monitored without treatment, and to determine the outcomes of surgery and the incidence of recurrences over time. Design and patients: National multicentric study of patients diagnosed of Rathke's cleft cyst (RCC- Spain) from 2000 onwards and followed in 15 tertiary centers of Spain. A total of 177 patients diagnosed of RCC followed for 67.3 months (6-215) and 88 patients who underwent surgery, (81 patients underwent immediate surgery after diagnosis and 7 later for subsequent growth) followed for 68.8 months (3-235). Results: The cyst size remained stable or decreased in 73.5% (133) of the patients. Only 44 patients (24.3%) experienced a cyst increase and 9 of them (5.1%) experienced an increase greater than 3 mm. In most of the patients who underwent surgery headaches and visual alterations improved, recurrence was observed in 8 (9.1%) after a median time of 96 months, and no predictors of recurrence were discovered. Conclusions: Rathke's cleft cysts without initial compressive symptoms have a low probability of growth, so conservative management is recommended. Patients who undergo transsphenoidal surgery experience rapid clinical improvement, and recurrences are infrequent. However, they can occur after a long period of time, although no predictors of recurrence have been identified.

Indexed as

Central Nervous System CystsAdolescentAdultAgedChildDisease ProgressionFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm Recurrence, LocalPituitary NeoplasmsSpainTreatment OutcomeYoung Adultcyst sizepituitaryRathke’s cleft cysttranssphenoidal surgeryvisual impairment

Identifiers

PMID38952395
PMCPMC11215184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.